TheJobsMapSenya Therapeutics jobs and careers
United Kingdom
About Senya Therapeutics
Developing first-in-class LRG inhibitor to harness pathogenic effect of TGF-β cascade in chronic kidney disease and cancer | a spin-out from University College London
- Employees
- 1 to 10
- Headquarters
- United Kingdom
Leadership
The top of Senya Therapeutics's org chart, with how many people report into each leader.
TT
Takashi Takenoshita
Chief Executive Officer
Jobs at Senya Therapeutics
No open positions right now. Explore more companies on TheJobsMap.